Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 17 of 17 for “"Propafenone"”.
-
Development of a sensitive and stereoselective high performance liquid chromatographic assay method for propafenone enantiomers in human plasma
Propafenone is a new class 1C antiarrhythmic agent with additional calcium antagonistic and beta-blocking activities. Clinically it is effective in the treatment of supraventricular and ventricular tachycardia, atrial and ventricular fibrillation, ventricular premature contractions and for the …
-
Roles of amino acids in the food effect : metabolic and pharmacokinetic studies on propafenone and metoprolol
… the kinetics and metabolism of two model drugs, propafenone and metoprolol, in the rat. By using HPLC/MS and MS/MS spectrometry, the metabolism of propafenone in the isolated, perfused rat liver was profiled. Hydroxylation in the terminal phenyl ring, which was not found in humans, was the major …
-
The interactions of Propafenone and its enantiomers with the major human forms of cytochrome P450 in terms of inhibition and metabolic rates
Propafenone is a class 1C antiarrhythmic drug used for the treatment of ventricular arrhythmias. Propafenone is a chiral compound which is normally administered as the racemate. The use of racemate therapy can be problematic as variability in both the pharmacodynamic and pharmacokinetic properties …
-
Protein binding displacement interactions between propafenone, 5-hydroxypropafenone and other antiarrhythmic drugs, HPLC analysis of indocyanine green
Propafenone (PF) is a class I antiarrhythmic agent used to treat ventricular and superventricular tachyarrhythmias. After oral administration, PF undergoes extensive metabolism. 5-hydroxypropafenone is one of the major active metabolites of PF. In this thesis, the displacement of PF and …
-
Η αποτελεσματικότητα του συνδυασμού προπαφαινόνης και ιμπουτιλίδης στην ανάταξη της κολπικής μαρμαρυγής πρόσφατης έναρξης
… conversion of persistent AF with a combined propafenone plus ibutilide regimen. Methods and results: One hundred consecutive patients (66 male, age 65±10 years) with persistent AF (mean duration 99±92 days) admitted for elective pharmacological cardioversion, were randomly assigned to either …
-
Propafenone pharmacokinetics : GLC-ECD analysis, metabolic induction by phenobarbital in non-smoking and smoking healthy volunteers, protein binding, pharmacodynamics in patients
Propafenone (PF) is a new class I antiarrhythmic agent used to treat supraventricular and ventricular tachyarrhythmias. This thesis reports: a) an in vitro protein binding study of PF in normal and uremic sera; b) a drug-drug interaction study of PF and phenobarbital in healthy human subjects and …
-
The in vitro characterization of the drug-protein binding of racemic propafenone, and its active metabolite 5-hydroxypropafenone in human serum, and in solutions of isolated human serum proteins
… plasma concentration-response relationship for propafenone (PF), a potent class 1 antiarrhythmic agent, has not yet been defined. A general pharmacological premise suggests that only the free drug is available to contribute to the observed pharmacological response. It has previously been shown …
-
CRISPR Interference Screening and Pharmacological Targeting of Sodium Channels in Triple-Negative Breast Cancer Cells
… Nav1.5 channel as a target in TNBC cells using propafenone, a clinically approved antiarrhythmic drug not previously studied in the cancer context. Electrophysiological analysis confirmed that propafenone (100 µM) significantly inhibited Na+ currents in MDA-MB-231 cells. Our findings highlight …
-
Investigating drug repositioning as a route to combat drug resistance in Plasmodium falciparum Malaria
… activity (Fluoxetine, Mitoxantrone, Nicardipine, Propafenone, Ivermectin and Nicardipine). Antimalarial activity was defined in the multi drug resistant Plasmodium falciparum strain K1 using the in vitro SYBR Green micro-titre drug assay. The IC50 values were as follows: Ivermectin 0.7067M, …
-
Σχέση της ηλεκτροκαρδιογραφικής διάρκειας του διαστήματος QT και της μηχανικής λειτουργίας του μυοκαρδίου
… (p=0.005) and amiodarone (p=0.017), but not for propafenone (p=0.139). Statistical analysis results between all measured pair of echocardiographic and electrocardiographic parameters were not significant except between ΔQTc and ΔPCTm(c) for the group of sotalol (p = 0.02, r = 0.43).Conclusion:QT …
-
Η ΠΡΟΛΗΠΤΙΚΗ ΑΝΤΙΑΡΡΥΘΜΙΚΗ ΘΕΡΑΠΕΙΑ ΣΤΗΝ ΟΞΕΙΑ ΦΑΣΗ ΤΟΥ ΕΜΦΡΑΓΜΑΤΟΣ ΜΥΟΚΑΡΔΙΟΥ:ΑΙΜΟΔΥΝΑΜΙΚΗ ΣΥΓΚΡΙΤΙΚΗ ΜΕΛΕΤΗ ΜΕΤΑΞΥ ΝΕΩΝ ΟΥΣΙΩΝ: ΣΙΒΕΝΖΟΛΙΝΗ, ΦΛΕΚΑΙΝΙΔΗ,ΜΕΞΙΛΕΤΙΝΗ,ΠΡΟΠΑΦΑΙΝΟΝΗ.
… (C), FLECAINIDE (F), MEXILETINE (M), AND PROPAFENONE (P). METHODS: THESE DRUGS WERE GIVEN RANDOMLY, SINGLE BLINDED, PLACEBO (PBO) CONTROLLED IN109 PTS, 58 MALE, 51 FEMALE, AGED 72.2+-12.1 (+-SD). ALL PTS WERE TREATED WITH BASIC CONVENTIONAL THERAPY PLUS ONE OF THE DRUGS (4 GROUPS OF 20) …
-
Supraventrikulinės tachikardijos gydymas nėštumo laikotarpiu. Klinikinis atvejis. Literatūros analizė /
… If these drugs are ineffective, flecainide or propafenone may be prescribed, which are also recommended for pregnant women with Wolf-Parkinson-White syndrome, and without structural or ischaemic heart disease. Fluoroless catheter ablation can be performed from the second trimester when medical …
-
Aclassical features of propranolol pharmacokinetics.
… and four other cardiovascular drugs (verapamil, propafenone, lidocaine, and nitroglycerin) are also reviewed. The first-pass metabolism of these agents is inconsistent with traditional models which assume that the hepatic extraction ratio of a drug is constant in each individual. The unusual …
-
Potassium channel expression and function in the N9 murine microglial cell line
… selective blocker Tram34 and the Kv1.5 inhibitor propafenone (PPF) significantly decreased LPS-induced NO in agreement with data in primary microglia. Ba2+ that inhibits inwardly rectifying potassium channels as well as K2p6.1 also significantly attenuated LPS-induced microglial activation. …
-
Einfluß und Wirksamkeit von Propafenon auf ischämiebedingte EKG-Veränderungen und ventrikuläre Arrhythmien während akutem, iatrogen induziertem Koronarverschluß (PTCA) im Vergleich zu Placebo
Die koronare Herzerkrankung ist mit einem deutlich erhöhten Risiko für das Auftreten eines plötzlichen Herztodes verbunden. Verantwortlich sind meist maligne ventrikuläre Tachyarrhythmien, wobei der Interaktion einer myokardialen Ischämie und dem Auftreten der ventrikulären Arrhythmie eine …
-
Κιρκάδια μεταβλητότητα της κολπικής και κοιλιακής ανερέθιστης περιόδου σε βηματοδοτημένους ασθενείς. Ο ρόλος των διακυμάνσεων του αυτόνομου νευρικού συστήματος και η επίδραση της προπαφαινόνης στις ηλεκτροφυσιολογικές ιδιότητες των κόλπων και των κοιλιών
Η καθιερωµένη αντίληψη, όσον αφορά τους στόχους των ρυθµιστικών µηχανισµών του ανθρώπου µε βάση τις αντιλήψεις της κλασικής ιατρικής είναι αυτή της οµοιοστασίας, της διατήρησης σταθερής δηλαδή εσωτερικής ισορροπίας. Η θεώρηση αυτή ευχεραίνει την κατανόηση των φυσιολογικών και παθοφυσιολογικών …